4
Changes in Ownership
NOVAVAX INC Filed Acc 0001209191-21-067151
President, R&D sold 2,083 shares at an average $218.07 ($454,247)
- President, R&D gave up 647 shares (to pay taxes)
- President, R&D acquired 3,460 shares (option exercise)
- President, R&D returned 38 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Glenn Gregory M · President, R&D
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-26 | Exercise or conversion : show line 1 in the form | +2,083 | $5.95 | $12,394 | 6,144 | D |
| 2021-11-26 | Sale : show line 2 in the form | −185 | $215.00 | $39,776 | 5,959 | D |
| 2021-11-26 | Sale : show line 3 in the form | −260 | $216.19 | $56,209 | 5,699 | D |
| 2021-11-26 | Sale : show line 4 in the form | −331 | $217.36 | $71,946 | 5,368 | D |
| 2021-11-26 | Sale : show line 5 in the form | −626 | $218.25 | $136,627 | 4,742 | D |
| 2021-11-26 | Sale : show line 6 in the form | −412 | $219.25 | $90,333 | 4,330 | D |
| 2021-11-26 | Sale : show line 7 in the form | −155 | $220.22 | $34,134 | 4,175 | D |
| 2021-11-26 | Sale : show line 8 in the form | −114 | $221.24 | $25,222 | 4,061 | D |
| Open-market sales · 2,083 sh · avg $218.07 · $454,247 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-11-26 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −2,083 | $5.95 | 2029-09-26 | 2,083 | 45,834 | D |
| 2021-11-26 | Exercise or conversion : show line 13 in the form Stock Appreciation Right | −1,377 | $5.95 | 2029-09-26 | 1,377 | 30,296 | D |
Loading xslF345X03/doc4.xml…